Russian-Hungarian cooperation in the pharmaceutical sector and the impact of anti-russian sanctions

Author:

Bakó Tamás1,Aidrоus Irina Ahmed Zein2

Affiliation:

1. Miskolc University

2. Peoples' Friendship University of Russia

Abstract

The analysis of the possibilities and directions of Russian-Hungarian bilateral cooperation in the field of pharmaceuticals carried out by the authors allowed us to assert that in the conditions of anti-Russian Western sanctions, the situation in the domestic pharmaceutical industry in terms of demand and supply of medicines has significantly worsened. The pharmaceutical industry remains important both from the point of view of ensuring public health and national security in this area, and high innovation. The authors conclude that it is necessary to strengthen international cooperation in this area, especially with states that traditionally have high achievements in it and a long history of interaction with Russian structures. One of these countries is Hungary. The article emphasizes that both countries are interested in cooperation in this area, relying on the ties traditionally formed during the socialist period and a certain complementarity. It is also noted that under the conditions of sanctions, the Russian pharmaceutical industry maintains both positive dynamics and maintains a high level of competitiveness of manufacturers in the domestic market.

Publisher

Plekhanov Russian University of Economics (PRUE)

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference8 articles.

1. Asmyatullin R., Aydrus I., Sabolch N. Mezhdunarodnaya torgovlya mezhdu Vengriey i Rossiey v ramkakh razvitiya farmatsevticheskoy promyshlennosti [International Trade between Hungary and Russia in the Framework of the Development of the Pharmaceutical Industry]. Mezhdunarodnaya torgovlya i torgovaya politika [International Trade and Trade Policy], 2021, Vol. 7, No. 4 (28). pp. 79–92. (In Russ.). DOI: 10.21686/2410-7395-2021-3-79-92

2. Balakin K. V., Ayginin A. A, Ivashchenko A. A. Rossiyskaya farmatsevticheskaya otrasl v gorizonte 2030. Analiticheskiy obzor [Russian Pharmaceutical Industry in the Horizon 2030. Analytical Review]. Dolgoprudnyy, 2021. (In Russ.).

3. Bykova E. A. Innovatsionnye protsessy na rossiyskom farma-tsevticheskom rynke [Innovative Processes in the Russian Pharmaceutical Market]. Vestnik universiteta. [Bulletin of the University], 2020, No. 8, pp. 57–64. (In Russ.). DOI: 10.26425/1816-4277-2020-8-57-64

4. Dremova N. B., Solomka S. V. Mirovoy farmatsevticheskiy rynok: trendvotching [The World Pharmaceutical Market: Trendwatching]. Laboratornaya i klinicheskaya meditsina. Farmatsiya. [Laboratory and Clinical Medicine. Pharmacy], 2022, Vol. 2, No. 1, pp. 56–68. (In Russ.). DOI 10.14489/lcmp.2022.01.pp.056-068

5. Kostin K. B., Shanava L. A. Klyuchevye tendentsii razvitiya rossiyskogo farmatsevticheskogo rynka v usloviyakh neopredelennosti [Key Trends in the Development of the Russian Pharmaceutical Market under Conditions of Uncertainty]. Ekonomika, predprinimatelstvo i parvo [Economics, Entrepreneurship and Law.], 2022, Vol. 12, No. 5, pp. 1639–1658. (In Russ.). DOI: 10.18334/epp.12.5.114635.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3